Shine-On BioMedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	44.66	102.02	373.16	824.98
Short-Term Investments	999	1,035	793	81
Cash & Short-Term Investments	1,044	1,137	1,166	905.98
Cash Growth	-8.21%	-2.50%	28.72%	-
Accounts Receivable	-	10	-	-
Other Receivables	2.31	2.06	1.18	-
Receivables	2.31	12.06	1.18	-
Prepaid Expenses	6.34	4.57	1.49	0.32
Other Current Assets	-	-	0	-
Total Current Assets	1,052	1,154	1,169	906.31
Property, Plant & Equipment	2.83	1.54	3.03	3.99
Other Intangible Assets	3.62	3.59	3.36	1.24
Long-Term Deferred Tax Assets	-	0.04	2.27	-
Other Long-Term Assets	1.03	0.89	0.28	0.28
Total Assets	1,060	1,160	1,178	911.82
Accounts Payable	-	2.86	-	0.19
Accrued Expenses	0.26	0.57	0.01	1
Current Portion of Leases	1.24	0.54	0.54	0.97
Other Current Liabilities	39.09	19.29	2.61	0.59
Total Current Liabilities	40.6	23.26	3.17	2.74
Long-Term Leases	1.36	-	0.98	1.52
Long-Term Deferred Tax Liabilities	0.26	-	-	-
Total Liabilities	42.21	23.26	4.14	4.26
Common Stock	498	498	498	430
Additional Paid-In Capital	703.6	703.6	703.6	486
Retained Earnings	-184.03	-65.14	-27.98	-8.43
Shareholders' Equity	1,018	1,136	1,174	907.57
Total Liabilities & Equity	1,060	1,160	1,178	911.82
Total Debt	2.6	0.54	1.52	2.48
Net Cash (Debt)	1,041	1,136	1,165	903.5
Net Cash Growth	-8.40%	-2.42%	28.90%	-
Net Cash Per Share	20.90	22.82	25.65	48.91
Filing Date Shares Outstanding	49.8	49.8	49.8	49.8
Total Common Shares Outstanding	49.8	49.8	49.8	49.8
Working Capital	1,012	1,130	1,166	903.57
Book Value Per Share	20.43	22.82	23.57	18.22
Tangible Book Value	1,014	1,133	1,170	906.33
Tangible Book Value Per Share	20.36	22.75	23.50	18.20
Machinery	1.23	1.86	1.79	1.31
Leasehold Improvements	0.02	0.37	0.37	0.37

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.